Ledger.Open graph →
SEC Form D · filed December 11, 2015

Thrive Bioscience, Inc

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Beverly, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Dave Myers · New York, NYDirectorBrock P. Reeve · Beverly, MADirectorPeter M. Carlton · Los Angeles, CAExec · DirectorAlan P. Blanchard · Beverly, MAExec · DirectorAndrew K. Tsai · New York, NYExec · DirectorGuy P. Broadbent · Beverly, MADirectorMichael Katz · New York, NYExec · DirectorGuy P. Broadbent · Beverly, MADirectorBrock P. Reeve · Beverly, MADirectorRobert A. Day · Los Angeles, CADirectorMichael P. Finney · Beverly, MADirectorThomas F. Farb · Beverly, MAExec · DirectorAndrew Katz · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗